Sponsored Videos

Amar Dixit, MD, MBA, FACAAI, FAAAI discusses how intranasal epinephrine (Neffy) presents an effective alternative to traditional autoinjectors for anaphylaxis treatment, addressing key barriers like needle phobia, device portability, and storage constraints while demonstrating comparable or superior pharmacokinetic and physiological responses to intramuscular delivery methods.

The content of this program has been supported by ARS Pharmaceuticals

Todd W. Frieze, MD, discusses the therapeutic role of TSH suppression in differentiated thyroid cancer, as well as treatment goals and ongoing surveillance strategies.

Alex Tessnow, MD, reviews the presentation of hypothyroidism among elderly patients and outlines key considerations for treatment.

Experts share an overview of IBS-C and CIC in adult patients and explore solutions for addressing the challenges leading to treatment discontinuation. They also discuss the impact of variable onset of individual abdominal and bowel symptom response, as well as the role of adverse effects on treatment adherence in patients with IBS-C and CIC. And finally, they review strategies for setting treatment expectations and highlight the importance of an effective patient-provider relationship and optimizing long-term clinical outcomes for these chronic conditions.

An expert in the management of hypothyroidism shares valuable insights on effective patient communication. She emphasizes the non-specific nature of symptoms and underscores the significance of treatment compliance in goal setting. Additionally, she discusses the factors affecting TSH values and highlights the narrow therapeutic range of thyroid medication, with an emphasis on proper administration.